Credit Agricole
RCUS icon

Credit Agricole’s Arcus Biosciences RCUS Stock Holding History

Credit Agricole’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,200
Closed -$170K – 727
2021
Q2 		$170K Buy
6,200
+2,000
+48% +$57.1K ﹤0.01% 374
2021
Q1 		$118K Buy
+4,200
New +$146K ﹤0.01% 379

Other funds holding RCUS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Credit Agricole's RCUS Position: Q3 2021 in Review

Credit Agricole sold out of Arcus Biosciences (RCUS) in Q3 2021, closing a stake of 6,200 shares — an estimated $170K sold.

Credit Agricole first reported a position in RCUS in Q1 2021 and held it in 2 quarters. The position peaked at $170K in Q2 2021. 131 funds tracked by Wall St. Rank hold RCUS as of Q3 2021.

  • Credit Agricole reported no remaining Arcus Biosciences position as of Q3 2021 after selling out during the quarter.
  • Credit Agricole sold 6,200 Arcus Biosciences shares in Q3 2021, an estimated $170K.
  • Credit Agricole first reported a position in Arcus Biosciences in Q1 2021 and held it in 2 quarters.
  • Credit Agricole's Arcus Biosciences position peaked at $170K in Q2 2021.
  • 131 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2021.

Based on Credit Agricole's 13F filing for Q3 2021, filed 15 Nov 2021.